BCRX
Biocryst Pharmaceuticals IncCompany with tickers: BCRX
Market Cap
$2.50B
Shares Outstanding
254,162,660
CIK
882796
CUSIP
09058V103
13F Activity (30d)
5 filings
4 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Jon P. Stonehouse | director | Appointed | 2026-06-12 |
| Amy E. McKee, M.D. | director | Appointed | 2026-06-12 |
| Theresa M. Heggie | director | Appointed | 2026-06-12 |